IP Verse

Method For Production Of F-18 Labeled Amyloid Beta Ligands - EP2579902

The patent EP2579902 was granted to Piramal Imaging on Aug 14, 2019. The application was originally filed on May 30, 2011 under application number EP11723431A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2579902

PIRAMAL IMAGING
Application Number
EP11723431A
Filing Date
May 30, 2011
Status
Patent Maintained As Amended
Jul 12, 2019
Publication Date
Aug 14, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELI LILLYApr 12, 2018SUAREZ MILESWITHDRAWN

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010113763
DESCRIPTIONWO2006066104
DESCRIPTIONWO2007126733
DESCRIPTIONWO2010078370
EXAMINATIONWO2011003591
INTERNATIONAL-SEARCH-REPORTUS2010113763
INTERNATIONAL-SEARCH-REPORTWO2006066104
OPPOSITIONWO2004043497
OPPOSITIONWO2008009444
OPPOSITIONWO2009059977
OPPOSITIONWO2011003591
OPPOSITIONWO2011151283

Non-Patent Literature (NPL) Citations (57) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BLENNOW ET AL., LANCET, (20060729), vol. 368, no. 9533, pages 387 - 403
DESCRIPTION- CAREY, SUNDBERG, ORGANISCHE SYNTHESE, (1995), pages 279 - 281
DESCRIPTION- C. C. ROWE ET AL., LANCET NEUROLOGY, (2008), vol. 7, pages 129 - 135
DESCRIPTION- CHITI ET AL., ANNU REV BIOCHEM., (2006), vol. 75, pages 333 - 66
DESCRIPTION- C.-H. YAO ET AL., APPLIED RADIATION AND ISOTOPES, (2010), vol. 68, pages 2293 - 2297
DESCRIPTION- C. ROWE ET AL., LANCET NEUROLOGY, (2008), vol. 7, pages 1 - 7
DESCRIPTION- "Fluorine-18 Labeling Methods: Features and Possibilities of Basic Reactions", COENEN, PET-Chemistry - The Driving Force in Molecular Imaging, SPRINGER, (2006), pages 15 - 50
DESCRIPTION- G. CASALE ET AL., WORLD JOURNAL OF NUCLEAR MEDICINE, (2010), page S-174
DESCRIPTION- GREENE, WUTS, Protecting groups in Organic Synthesis, pages 494 - 653
DESCRIPTION- H. WANG ET AL., NUCLEAR MEDICINE AND BIOLOGY, (2011), vol. 38, pages 121 - 127
DESCRIPTION- NETSCHER, RECENT RES. DEV. ORG. CHEM., (2003), vol. 7, pages 71 - 83
DESCRIPTION- NORDBERG, EUR J NUCL MED MOL IMAGING., (200803), vol. 35, no. 1, pages 46 - 50
DESCRIPTION- PETRELLA JR ET AL., RADIOLOGY, (2003), vol. 226, pages 315 - 36
DESCRIPTION- S. R. CHOI ET AL., THE JOURNAL OF NUCLEAR MEDICINE, (2009), vol. 50, pages 1887 - 1894
DESCRIPTION- SYNTHESIS, (1982), pages 85 - 125
DESCRIPTION- "Synthesis Modules and Automation in F-18 labeling", KRASIKOWA, PET-Chemistry - The Driving Force in Molecular Imaging, SPRINGER, (2006), pages 289 - 316
DESCRIPTION- W. ZHANG ET AL., NUCLEAR MEDICINE AND BIOLOGY, (2005), vol. 32, pages 799 - 809
DESCRIPTION- Y. LIU ET AL., NUCLEAR MEDICINE AND BIOLOGY, (2010), vol. 37, pages 917 - 925
INTERNATIONAL-SEARCH-REPORT- ZHANG ET AL, "F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain", NUCLEAR MEDICINE AND BIOLOGY, ELSEVIER, NY, US, (20051101), vol. 32, no. 8, doi:10.1016/J.NUCMEDBIO.2005.06.001, ISSN 0969-8051, pages 799 - 809, XP005129336 [XD] 11-13 * abstract * * scheme 3 * * page 807, column 2, paragraph 1 - page 808, column 1, paragraph 2 * [I] 1-10
INTERNATIONAL-SEARCH-REPORT- S. R. CHOI ET AL, "Preclinical Properties of 18F-AV-45: A PET Agent for A Plaques in the Brain", THE JOURNAL OF NUCLEAR MEDICINE, (20091016), vol. 50, no. 11, doi:10.2967/jnumed.109.065284, ISSN 0161-5505, pages 1887 - 1894, XP055007729 [XD] 11-13 * abstract * * page 1889, column 1, paragraph 3 - column 2, paragraph 1 * [I] 1-10
OPPOSITION- Declaration, filed March7,2016 + Curriculum Vitae Santiago Bullich Roig
OPPOSITION- DUCHARME, J. ET AL, JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, (20090900), vol. 37, no. 3, pages 164 - 169
OPPOSITION- Grierson et al., "A Radiosynthesis of Fluorine-18 Fluoromisonidazole", J. Nucl. Med., (19890300), vol. 30, pages 343 - 350, XP000033832
OPPOSITION- GRIERSON ET AL, J. NUCL. MED., (19890300), vol. 30, no. 3, pages 343 - 350, XP000033832
OPPOSITION- Hung, "Comparison of various requirements of the quality assurance procedures for 18F-FDG injection", J. Nucl. Med., (20020000), vol. 43, no. 11, pages 1495 - 1506, XP002678504
OPPOSITION- HUNG ET AL, "Comparison of various requirements of the quality assurance procedures for 18F-FDG injection", J. NUCL. MED, (20020000), vol. 43, no. 11, pages 1495 - 1506, XP002678504
OPPOSITION- JACOBSON, M. ET AL, APPLIED RADIATION AND ISOTOPES, (20090000), vol. 67, pages 990 - 995
OPPOSITION- Kumar et al., "Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.", J. Pharm. Pharm. Sci., (20070000), vol. 10, pages 256s - 265s, XP055481274
OPPOSITION- KUMAR ET AL, J. PHARM. PHARM. SCI, (20070000), vol. 10, pages 256s - 265s, XP055481274
OPPOSITION- Letter - Department of Health & Human Services - NDA 21-870
OPPOSITION- LISTER-JAMES, J. ET AL, SEMINARS IN NUCLEAR MEDICINE, (20110000), pages 557 - 562
OPPOSITION- PATT ET AL, J RADIOANAL NUCL CHEM, (20100000), vol. 284, pages 557 - 562
OPPOSITION- SERDONS, K. ET AL, JNM -THE JOURNAL OF NUCLEAR MEDICINE, (20080000), vol. 48, page 2071
OPPOSITION- Springer Science + Business Media, LLC, Basics of PET Imaging Physics, Chemistry and Regulations, (20100000), pages 151 - 178
OPPOSITION- ZHANG ET AL, NUCLEAR MEDICINE AND BIOLOGY, (20070000), vol. 34, pages 89 - 97
OPPOSITION- ALAUDDIN ET AL, J. LABEL. COMPD. RADIOPHARM, (20050000), vol. 48, pages 941 - 950, XP055481321
OPPOSITION- Alauddin et al., "Synthesis of 3′‐deoxy‐3′‐[18F]fluoro‐1‐β‐D‐xylofuranosyluracil ([18F]‐FMXU) for PET", J. Label. Compd. Radiopharm., (20050927), vol. 48, pages 941 - 950, XP055481321
OPPOSITION- Lehel et al., "HPLC methods for the purification of [ 11 C]-labelled radiopharmaceuticals: reversal of the retention order of products and precursors", J. Label. Compd. Radiopharm., (20090515), vol. 52, pages 177 - 181, XP055481264
OPPOSITION- LEHEL ET AL, J. LABEL. COMPD. RADIOPHARM, (20090515), vol. 52, pages 177 - 181, XP055481264
OPPOSITION- Paolillo et al., "A fully automated synthesis of [ 18 F]-FEAU and [ 18 F]-FMAU using a novel dual reactor radiosynthesis module", J. Label. Compd. Radiopharm., (20090000), vol. 52, no. 13, pages 553 - 558, XP055136164
OPPOSITION- PAOLILLO ET AL, J. LABEL. COMPD. RADIOPHARM, vol. 52, pages 553 - 558, XP055136164
OPPOSITION- KÄMÄRÄINEN ET AL, J. OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, (20040000), vol. 47, pages 37 - 45, XP055481316
OPPOSITION- Kämäräinen, "Preparation of fluorine-18-labelled fluoromisonidazole using two different synthesis methods", J. Label. Compd. Radiopharm., (20040120), vol. 47, pages 37 - 45, XP055481316
OPPOSITION- Gopal, "9 Regulations Governing PET Radiopharmaceuticals", Basics of PET Imaging: Physics, Chemistry, and Regulations Second Edition, Springer Science + Business Media, LLC, (20100000), pages 151 - 178, XP055481252
OPPOSITION- KATSIFIS ET AL, APPL. RADIAT. ISOT, (20060000), vol. 64, pages 27 - 31, XP005134387
OPPOSITION- Katsifis et al., "A rapid and efficient preparation of [<123>I]radiopharmaceuticals using a small HPLC (Rocket<(>R)) column", Appl. Radiat. Isot., (20060000), vol. 64, pages 27 - 31, XP005134387
OPPOSITION- Scott et al., "Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography", Appl. Radiat. Isot., (20090000), vol. 67, no. 1, pages 88 - 94, XP025686472
OPPOSITION- SCOTT, P. ET AL, APPLIED RADIATION AND ISOTOPES, (20090000), vol. 67, pages 88 - 94, XP025686472
OPPOSITION- "Radiolysis of 2-[<18>F]fluoro-2-deoxy-d-glucose ([<18>F]FDG) and the role of ethanol and radioactive concentration", Appl. Radiat. Isot., (20090000), vol. 67, no. 6, pages 990 - 995, XP026037492
OPPOSITION- BRETTSCHNEIDER ET AL, J. CHROMATOGR. B, vol. 878, pages 763 - 768, XP026933291
OPPOSITION- Brettschneider, "Replacement of acetonitrile by ethanol as solvent in reversed phase chromatography of biomolecules", J. Chromatogr. B, (20100000), vol. 878, pages 763 - 768, XP026933291
OPPOSITION- BOURGEOIS ET AL, J. PHARM. BIOMED. ANAL., (20070000), vol. 45, pages 154 - 157, XP022241833
OPPOSITION- Bourgeois et al., "Purification of [<18>F]-fluoro-l-thymidine ([<18>F]-FLT) for positron emission tomography imaging", J. Pharm. Biomed. Anal., (20070000), vol. 45, pages 154 - 157, XP022241833
OPPOSITION- "F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain", Nucl. Med. Biol., (20050000), vol. 32, pages 799 - 809, XP005129336
OPPOSITION- Ducharme et al., "Practical Aspects of 18F-FDG PET When Receiving 18F-FDG from a Distant Supplier.", J. Nucl. Med. Technol., (20090900), vol. 37, no. 3, pages 164 - 169, XP055481244
OPPOSITION- Serdons et al., "The Prescence of Ethanol in Radiopharmaceutical Injections", J. Nucl. Med., (20080000), vol. 49, page 2071, XP055481242
OPPOSITION- Choi et al., "Preclinical Properties of 18F-AV-45: A PET Agent for A Plaques in the Brain", J. Nucl. Med., (20090000), vol. 50, pages 1887 - 1894, XP055007729

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents